Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Those who begin antiretrovirals with a higher CD4 count and CD4 to CD8 ratio are more likely to experience immune recovery.
Just ask Nicholaus Johnson, a former “junkie” with AIDS who is now a sober college student helping the HIV community.
People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.
Her metamorphosis from gay banker to “trans-species reptilian” began after an HIV diagnosis in 1997.
Researchers will genetically engineer participants’ CD4 cells, disabling the attachment of the virus.
Defective copies of HIV distract the immune system in order to promote overall infection.
The country is urged to offer treatment to everyone who has HIV regardless of CD4 count; most cases are among young men.
Treating HIV early, before CD4s drop significantly, lowers the risk of infection-related cancers.
Researchers have found that in addition to CD4s, macrophage cells can harbor HIV even in the face of antiretroviral treatment.
Researchers have used the cutting-edge CRISPR/Cas9 gene-editing technology to identify five potential targets for HIV treatments.
U.S. Justice Department takes up the case and sues the NYPD over HIV discrimination.
In a post titled “Fighting My Way Up,” POZ blogger Aundaray Guess reflects on his struggles with adherence to his HIV medications.
Immunotherapy and an HIV vaccine are among the first round of grants from Fred Hutch’s Evergreen Fund.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.